Epocrates Names Andrew Hurd as President and CEO
March 26 2012 - 9:15AM
Epocrates, Inc. (Nasdaq:EPOC), a physician platform for clinical
content, practice solutions and health industry engagement,
announced the appointment of Andrew Hurd as president and chief
executive officer, effective immediately. He will also serve on the
company's board of directors.
"Andy stood out as a natural leader with a proven track record
and the expertise to generate growth and foster innovation. He has
the distinct experience mix we were seeking and an appreciation of
the complex healthcare industry," said Patrick Jones, chairman of
the Epocrates board of directors. "As a seasoned executive, we are
confident he will continue to drive this dynamic company to the
next level."
Hurd brings more than 20 years of healthcare IT experience and
leadership to Epocrates, including product and market innovation as
well as strategic partnerships. He joins Epocrates from Carefx,
acquired by Harris Corporation in 2011, where he served as chairman
and CEO for more than six years. During his tenure, Carefx
demonstrated strong growth in revenue, income and shareholder
value. Previously, Hurd held senior management positions at WebMD
Corp, CenterBeam, Inc. and QuadraMed Corporation. He also currently
serves on the board of directors for ABILITY Network Inc.
"Epocrates is an incredibly powerful and established brand among
healthcare professionals. It is an essential and trusted part
of physicians' daily practice and an ally in providing quality
patient care," said Hurd. "The company is positioned to play a
significant role in the high-growth mobile healthcare ecosystem,
and I'm excited to lead this company in its next chapter of growth
and innovation."
Peter Brandt will be stepping down as interim president and CEO
effective March 27, 2012. He will take on the newly appointed role
of vice chairman of the board of directors. As vice chairman,
Brandt will work closely with Hurd to provide strategic counsel and
ensure a smooth transition.
About Epocrates, Inc.
Epocrates, Inc. (Nasdaq:EPOC) is a leading physician platform
for essential clinical content, practice tools and health industry
engagement at the point of care. The Epocrates network consists of
1.4 million active members, including 50 percent of U.S.
physicians, who routinely use its solutions and services.
Epocrates' portfolio includes top-ranked medical apps, such as the
industry's #1 most used mobile drug reference, and valuable
manufacturer resources. Through these intuitive and reliable
resources, the company supports clinical decisions, helps improve
physician workflow and impacts patient outcomes. For more
information, please visit www.epocrates.com/company.
The Epocrates, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=11331
Epocrates is a trademark of Epocrates, Inc., registered in the
U.S. and other countries.
Forward-Looking Statements
Statements contained in this press release are forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements by their nature
address matters that are, to different degrees, uncertain.
Uncertainties and risks may cause Epocrates' actual results to be
materially different than those expressed in or implied by
Epocrates' forward-looking statements. For Epocrates, particular
uncertainties and risks include, among others: unexpected delays in
Epocrates delivering new products may occur, which would cause
revenues not to be as Epocrates expects; market acceptance of new
products, such as its EHR, may not be as Epocrates expects, which
would cause revenues not to be as Epocrates expects; and the impact
of competitive products and pricing may decrease demand for
Epocrates' products and/or force Epocrates to decrease the price of
its products. More detailed information on these and additional
factors that could affect Epocrates' actual results are described
in Epocrates' filings with the Securities and Exchange Commission,
including its Annual Report on Form 10-K filed with the Securities
and Exchange Commission on March 19, 2012. Except as required by
law, Epocrates undertakes no obligation to publicly update its
forward-looking statements.
CONTACT: INVESTORS & MEDIA:
Erica Sniad Morgenstern
Senior Director, Public Relations & Communications
Epocrates, Inc.
(650) 227-6907
ir@epocrates.com
Epocrates, Inc. (MM) (NASDAQ:EPOC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Epocrates, Inc. (MM) (NASDAQ:EPOC)
Historical Stock Chart
From Jul 2023 to Jul 2024